The paper of the week is An isoform of Dicer protects mammalian stem cells against multiple RNA viruses published in Science. The take-home from the abstract is that the data, “demonstrate that mammalian stem cells can protect themselves from some RNA viruses by expressing an alternatively spliced isoform of the enzyme Dicer called aviD, which potentiates […]
The FDA has sought injunctions in federal court against two stem cell clinic firms including the clinic chain Cell Surgical Network headquartered here in California and US Stem Cell in Florida. According to new documents filed by the government in federal court here in California there may be more ties between the clinic firms than
FDA alleges Cell Surgical Network links to US Stem Cell & COVID plan Read More »
Over the past half dozen or so years I’ve seen far more physicians describing themselves as a “stem cell doctor” or a “stem cell specialist.” Is there such a thing? Are they just saying that to attract and reassure potential customers getting unproven stem cell shots? What does Google think is a stem cell doctor?
How should we define a stem cell doctor? Read More »
Let’s start off today’s recommended reads with the topic of life extension. No controversy there, right? This comes to mind because of a new preprint from BioViva, Liz Parrish, and George Church. I’m hoping to cover this on our Stem Cell Channel on YouTube. Gene therapy and life extension research The preprint is entitled, “New
Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR Read More »
A few years ago a promotional website called Bioinformant popped up in the stem cell arena. It’s very different in some ways than most other stem cell-related websites that I’ve seen. It’s a marketing and promotion site. What’s the backstory? I believe there’s reason for concern here specifically related to Bioinformant promoting unproven stem cell
Review of Bioinformant, unproven stem cell clinic promotion, NIH & Pfizer as clients? Read More »
The idea of stem cell therapy for diabetes is both exciting and in a way practical. By that I mean that there’s a good common sense foundation here. The idea of stem cell therapy for diabetes What do I mean? If medical researchers can replace lost beta cells in the pancreas using stem cell-produced beta
Stem cell therapy for diabetes updates: expected IPO, CRISPR, new pubs, more Read More »
When someone uses the term “adult stem cells” you might think that simply means stem cells from adults. However, it’s not that simple. The goal of today’s post is to help you get all the key facts about adult stem cells. This includes the different types of adult stem cells and their clinical potential. What
What are adult stem cells & their clinical applications? Read More »
Sometimes the recommended weekly stem cell reads are just a bunch of papers I find intriguing, but more often they include at least one or more things that are not necessarily “recommended”. Instead these are items that stimulate discussion and debate. Today’s post includes one such complicated area on cord MSCs related to COVID-19 plus
Weekly stem cell reads: Pew, cord cells for COVID, more Read More »
A firm called Utah Cord Bank has been in the news related to stem cell clinics over the past year or two. Now they have received an FDA Warning Letter for a variety of manufacturing issues. Utah Cord Bank Background In terms of some brief backstory, Utah Cord Bank first popped up on my radar
FDA warning to stem cell clinic supplier Utah Cord Bank Read More »
Cancer stem cells are one of the most interesting areas of research, intersecting the stem cell and cancer fields. Today’s weekly reads post highlights some new cancer stem cell articles along with some other interesting papers. I also note a recent weak stem cell clinical trial paper that is not a recommended read but is
Weekly reads: cancer stem cells & other pubs plus a puzzler Read More »